Clinical and Pathologic Studies in Neuroendocrine Tumors

Withdrawn

• Conditions: Carcinoid Tumor; Neuroendocrine Tumors

• Registration Number: NCT00657332
• Lead Sponsor: Stanford University

Brief Summary

This research involves the study of neuroendocrine tumors in order to better understand how the disease grows and spreads. This study requires will use tissue collected from from biopsies performed during your regular medical care (i.e. tissue leftover after your diagnosis has been made) and/or blood and urine samples. This study may lead to the development of special materials that could be used, in the future, to treat neuroendocrine tumors or to follow the response of neuroendocrine tumors to treatment

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design

Study Timeline

• Study Start: 2007-07
• Study First Submitted: 2008-04-09
• Study First Submitted QC: 2008-04-11
• Study First Posted: 2008-04-14
• Primary Completion: 2008-06-17
• Study Completion: 2008-06-17
• Status Verified: 2023-11
• Last Update Submitted: 2023-11-21
• Last Update Posted: 2023-11-28

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Patients are eligible if they have a histologically proven neuroendocrine tumor and are 18 years of age or older

• Ability to understand and the willingness to sign a written informed consent document.

Read More

Exclusion Criteria

None

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified